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Abstract
Scope: To characterize diet-dependent miRNA profiles and their targets in the visceral adipose of mice with
polygenic susceptibility to type 2 diabetes.
Methods and results: Six-week NONcNZO10/LtJ (NZ10) and control SWR/J mice were subjected to high
protein-fish oil or control diets for 19 weeks and micro-RNA microarray analyses were implemented on visceral
adipose RNA. We found that 27 miRNAs were significantly induced and 10 significantly repressed in the VA of
obese NZ10 mice compared with controls. 12 selected regulated miRNAs were confirmed by RT-PCR based on the
microarray data and we demonstrated that the expression of these miRNAs remained unaltered in the VA of control
SWR mice. To assess the possible functional roles of miRNAs in adipogenesis, we also analyzed their expression
in 3T3-L1 cells during growth and differentiation. This revealed that suppression of miRNA-205 alone correlated
selectively with increased cell proliferation and lipid formation of adipocytes.
Conclusion: Diet and genetics control the expression of obesity-regulated miRNAs in the visceral adipose of
NZ10 mice.
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Introduction
Micro-RNAs (miRNAs) are short 21-23 nucleotide RNAs
that regulate gene expression at the posttranscriptional level [1,2].
Obesity and insulin resistance are key features of type 2 diabetes. In
obese individuals, increased adiposity is a consequence of increased
number and size of adipocytes. The relative degree of hypertrophy
versus hyperplasia influences the level of body fat and the metabolic
consequences of obesity [3,4]. The involvement of miRNAs in
adipocyte differentiation has been studied using 3T3-L1 cells wherein
selective miRNAs have been assigned various roles in pre-adipocyte
differentiation [5]. It is now known that several repressor miRNAs
implicated in adipogenesis are inversely expressed in the obese adipose
tissue [6] and this inverse regulatory pattern has been characterized
in mouse models of obesity and in humans [7]. To date microRNA
targets have only been identified in monogenic or diet-induced
models of obesity and diabetes. These models involve severe obesity
and hyperinsulinemia that is usually associated with hyperphagia
and extreme leptin levels. There have been no reported studies on
the regulation of microRNAs in polygenic models of obesity-induced
diabetes.
NONcNZO10/LtJ (NZ10) is a recombinant congenic strain for
obesity-induced type 2 diabetes that was developed at The Jackson
Laboratory (Bar Harbor, Maine). The polygenic nature with a
maturity-onset transition from impaired glucose tolerance to a
stable non-fasting hyperglycemia and a relatively mild obesity of the
mice closely resembles human T2D. The NZ10 mice differ from the
parent NZO/HILt strain in acquiring adiposity primarily in visceral
rather than subcutaneous fat depots and this may contribute to the
T2D-susceptibility phenotype [8]. Also, NZ10 mice accumulate more
visceral fat and intramuscular triglyceride levels relative to wild type
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C57BI/6J mice subjected to either low or high fat (6 or 11%) diet [9].
We have recently reported that a high protein-fish oil diet prevents
the development of obesity and type 2 diabetes in NZ10 mice and also
influences visceral adipose remodeling by regulating the expression of
matrix metalloproteinases and their inhibitors [10]. Here we report
that miRNA-205 is selectively implicated in adipocyte division and
lipid accumulation in vitro and in vivo.

Methods
Animals and diets
Four-week old male NZ10 mice and their non-diabetic SWR/J
counterparts were purchased from The Jackson Laboratory (Bar
Harbor, Maine). After 2 weeks of acclimatization mice were randomized
into 2 groups (at least 10 mice per group) to receive control (CD)
or High Protein-Fish Oil (HPO) diets for a period of 19 weeks [10].
Blood glucose after 12 hrs of fasting was measured with a glucometer
(Freestyle, Abbott Diagnostics). For tissue harvest, mice were fasted for
12-h, sacrificed by cervical dislocation and the visceral adipose depots
including epididymal, perirenal, and retroperitoneal rapidly dissected
and processed for RNA analysis.
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MicroRNA microarrays
Pooled samples (n=5 per group) were homogenized in Trizol
(Invitrogen, Carlsbad, CA) and total RNA was isolated. Quality of the
total RNA samples was assessed using UV spectrophotometry and
agarose gel electrophoresis. The samples were treated with DNAse
and low-molecular weight (LMW) RNA isolated by ultrafiltration
through YM-100 columns (Millipore) and subsequent purified using
a RNeasy MinElute Clean-Up Kit (Qiagen, Valencia, CA). RNA
samples were subjected to custom microarrays containing 374 probes
covering mouse mature microRNAs present in Sanger 9.0 mirBASE
at Ocean Ridge Biosciences (ORB, Palm Beach Gardens, FL). The
species-specific, unmodified oligonucleotide probes are 34-44 bases in
length from the Invitrogen Ncode Version 2.0 probe set (Invitrogen,
Carlsbad, CA). The microarrays were produced by Microarrays Inc.
(Huntsville, Alabama), and consisted of epoxide glass substrates
spotted in triplicate with each probe. The LMW RNA samples were
3’-end labeled with Oyster-550 fluorescent dye using the Flash Tag
RNA labeling Kit (Genisphere, Hatfield, PA). Labeled LMW RNA
samples were hybridized to the MicroRNA microarrays according to
conditions recommended in the Flash Tag RNA labeling Kit manual.
The microarrays were scanned on an Axon Genepix 4000B scanner,
and data was extracted from images using GenePix V4.1 software. The
data was preprocessed and normalized as described in Enquobahrie et
al. [11].

Real time PCR
MicroRNA expression levels were assayed by real time PCR using
the ABI 7900HT thermal cycler with custom assays (Life Technologies,
Grand Island, NY). PCR reactions were conducted at 95ºC for 10
min and then followed by 40 cycles (15 s at 95ºC, 60 s at 60ºC). The
following Assay IDs 000587, 000463, 002249, 002299, 000502, 002251,
002300, 000507, 000509, 000546, 001077, 002607, 001670, 001678 and
Mm01184322_m1were used for miRNAs -29c, 141, 143, 191, 200a,
200b, 200c, 203, 205, 335, 429, 665, 685, 691 and PPARγ respectively.
Eukaryotic 18S rRNA (Assay ID Hs99999901_s1) for PPARgamma
gene expression and snoRNA 202 and 234 (Assay IDs 1232, 1234) for
miRNA expression normalization were used.

Cell culture
Mouse 3T3-L1 preadipocytes were purchased from Zen-Bio
(Research Triangle Park, NC) and were cultured in preadipocyte
maintenance medium (PM-1-L1, Zen-Bio). For induction of
adipogenesis the cultured preadipocytes were grown to 100% confluency
and after 2 days the media was replaced with adipogenic differentiation
medium (DM-2-L1, Zen-Bio). After 3 days the DM-2-L1 media was
replaced by adipocyte maintenance medium (AM-1-L1, Zen-Bio).
Adipocytes were fed with AM-1-L1 every 3rd day. Preadipocytes were
transfected with pre or anti-miR-205 oligos (Life Technologies, Grand
Island, NY) according to manufacturer’s instructions.

RNA isolation and reverse transcription 3T3-L1 cells
Total RNA was isolated from 3T3-L1 preadipocytes and adipocytes
using miRVana kit (Life Technologies, Grand Island, NY). The
concentration of RNA was determined by spectrophotometry, using
Nanodrop-1000 (Nanodrop Technologies, Wilmington, DE). Reverse
transcription for gene expression was performed on 200 ng/μl of RNA
with High-Capacity cDNA Reverse Transcription kit using random
primers (Life Technologies, Grand Island, NY). Reverse transcription
for miRNA expression was performed on 10 ng of RNA with Taqman
J Diabetes Metab
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miRNA reverse transcription kit using custom primers for each miRNA
(Life Technologies, Grand Island, NY).

Cell cycle proliferation
Cell proliferation of pre or anti-miR-205 transfected preadipocytes
was measured using cell proliferation ELISA, BrdU colorimetric kit
(Roche, Indianapolis, IN) as per manufacturer’s instructions. Briefly,
3T3-L1 preadipocytes were transfected with Pre (10 μM)- or AntimiR-205 (10 μM) along with controls (transfection medium) in a
96 well plate for 48 h followed by incubation with 10uM BrdU for
2.5 h. The cells were then fixed and incubated with Anti-BrdU POD.
Incubation with substrate was done for 20 minutes and the reaction
was stopped using stop solution. Absorbance was measured using a
plate reader at 450 nm.

Oil red O staining
Preadipocytes were transfected with pre (10 μM) or anti-miR-205
(10 μM) in 6 well plates. Oil Red O staining at Day 3 and Day 7
visualized adipocytes formed. For Oil Red O staining the adipocyte
maintenance medium was aspirated and cells were washed 3 times with
phosphate buffered saline (PBS) and fixed with 4% paraformaldehyde
for 30 minutes. After 30 minutes the paraformaldehyde solution was
removed and cells were rinsed 3 times with PBS and twice with water.
Oil red O solution was added and the cells were further incubated for
50 minutes. After 50 minutes the stain was aspirated and cells were
rinsed 3 times with water. The stained cells were photographed and
dye extraction solution was added. The plate was set on an orbital
shaker for 20 minutes and the extracted dye was transferred to a 96
well plate and absorbance measured at 520 nm with a plate reader
spectrophotometrically. Stain extracted from wells lacking cells
represents non-specific binding of the dye to the plate and its value was
subtracted from the absorbance of experimental wells.

Statistical analysis
Data are expressed as mean ± SEM. Differences between two
groups were analyzed by Student’s “t” test and Mann-Whitney U test
using Graphpad Prism 5.0.

Results and Discussion
We recently reported that the HPO diet significantly reduced the
body weight of NZ10 mice compared with their counterparts on CD
or the SWR mice on either diet [10]. NZ10 mice fed CD had increased
body fat and displayed hyperinsulinemia and fasting hyperglycemia
that was not seen in mice fed HPO or SWR mice fed either diet [10].
These results confirm the development of a diabetogenic phenotype
in NZ10 mice fed CD. NZ10 mice may be useful for identifying
susceptibility loci and genetic background-diet interactions [12-14]. As
a first step towards such analyses we implemented micro-RNA arrays
using RNA from the VA of NZ10 and SWR strains fed CD or HPO
diets as described [10]. miRNA microarray analysis of the VA revealed
27 miRNAs that were significantly up-regulated and 10 miRNAs that
were significantly down-regulated in the NZ10 mice fed HPO diet vs.
those fed CD for 19 weeks (Figure 1, Tables 1-2). RT-PCR confirmed
increased expression of 12 up-regulated miRNAs in the VA of NZ10
mice fed HPO. Results from RT-PCR analyses of individual RNA
samples are in good agreement with the microarrays (Figure 2, Table
1-2). The HPO diet significantly up-regulated the expression of the
miR-200 family as well as miRs- 143, 191 and 205 in the VA of NZ10
mice but not in SWR mice suggesting complementary roles for diet and
genetics in the regulation of these miRNAs (Figure 2).
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NZ10 mice (Table 1). Similarly miRs- 1 and 122a were inhibited in
the adipose of DIO mice and showed significant up-regulation in
the obese NZ10 mice (Table 2) [15]. Another example of a miRNA
showing differential expression patterns in the adipose of obese mice
is miR-143. Its expression in the present study was significantly downregulated in the VA of obese-diabetic NZ10 mice fed CD compared to
those fed HPO and unchanged in SWR mice (Figure 2). These results
help resolve discrepancies in the literature where miR-143 has been
shown to be unchanged [15], decrease [6], or increased [16] in parallel
with obesity. The differences could be due to genetic background or
different responses of miR-143 in different fat depots.

Figure 1: miRNA expression analysis of visceral adipose tissue using
microarray analysis. Heat maps show differences in miRNA levels in the VA
of NZ10 and SWR mice fed CD and HPO diet for 19 weeks. Inset heat map
shows miRNAs significantly up-regulated by HPO diet only in the VA of NZ10
mice and not the SWR mice of same age on either diet.

Because members of miR-200 family and miR-205 showed
significant inhibition in the VA of obese mice, we chose to evaluate
whether any of these miRNAs are implicated in adipogenesis. We
quantified the expression of miRs- 29c, 141, 191, 200a, 200b, 200c, 205,
335 and PPARγ in 3T3-L1 cells at different stages of differentiation.
MiRs- 200a, 200b and 141 were below levels of RT-PCR detection
in 3T3-L1 cells either as preadipocytes or after differentiation into
adipocytes. The levels of miRs- 29c, 191 and 200c increased up to Day
3 and then reverted to preadipocyte levels by Day 7 (Figures 3a-3d).
The trend was similar for miR-335 expression with a peak induction

microRNA ID

NZ10 HPO/CD

SWR HPO/CD

microRNA ID

NZ10 HPO/CD

SWR HPO/CD

mmu-miR-100

4.3

0.8

mmu-miR-1

-3.4

-1.66

mmu-miR-101a

3.5

1.3

mmu-miR-122a

-3.71

1.0

mmu-miR-101b

3.4

0.6

mmu-miR-199b

-3.93

-1.42

mmu-miR-106a

7.5

1.2

mmu-miR-215

-6.81

9.9

mmu-miR-10a

6.8

1.0

mmu-miR-341

-3.45

-2.5

mmu-miR-10b

7.5

1.2

mmu-miR-342

-3.68

1.4

mmu-miR-29c

4.4

0.5

mmu-miR-379

-3.37

1.4

mmu-miR-140*

5.4

0.6

mmu-miR-483

-5.29

-2.5

mmu-miR-141

54.1

1.1

mmu-miR-696

-4.16

-3.33

-4.54

-5.0

mmu-miR-143

2.2

1.2

mmu-miR-702

mmu-miR-148a

20.3

0.9

mmu-miR-148b

4.6

0.6

Table 2: HPO diet down-regulated miRs in visceral adipose of NZ10 mice.

mmu-miR-182

37.1

0.9

mmu-miR-187

3.7

1.4

mmu-miR-194

4.7

0.7

mmu-miR-200a

89.3

0.8

mmu-miR-200b

173.6

1.0

mmu-miR-200c

1555.7

1.1

mmu-miR-203

2.5

0.5

mmu-miR-204

26.8

1.2

mmu-miR-205

52.3

0.8

mmu-miR-375

145.7

1.0
1.0

mmu-miR-429

80.8

mmu-miR-542-5p

8.5

0.7

mmu-miR-665

4.9

2.1

mmu-miR-691

3.6

2.2

mmu-miR-744

34.6

4.5

Table 1: HPO diet up-regulated miRs in visceral adipose of NZ10 mice.

Our results on the expression trends of the miR-200 family: miRs200a, 200b, 200c, 141 and 429 are consistent with results reported
previously using epididymal fat pads of DIO mice fed high fat diet
[15]. Whereas, the expression of miR -148b was significantly inhibited
in the VA of obese-diabetic NZ10 mice and the levels of miR-379
previously reported to be up-regulated in the adipose of high fat fed
DIO mice was also significantly induced in the VA of obese-diabetic
J Diabetes Metab
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Figure 2: Real time PCR analysis of miRNAs revealed significant upregulation in the VA of NZ10 mice fed HPO over those fed CD (Purple Bars)
and no change in expression of these miRNAs in VA of SWR mice fed any
diet (Blue Bars). snoRNA-202 was used as an endogenous control and fold
changes were calculated over CD fed mice.
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Figure 3: miRNA expression as assessed by real time PCR at Day 0, 3 and 7 of 3T3-L1 preadipocyte differentiation. miRNA expression for Day 0, 3 and 7 are
relative to the preadipocyte levels and snoRNA-234 and 18S rRNA were used as endogenous controls for normalization of miRNA and PPARgamma gene expression
respectively. A schematic representation describing the 3T3-L1 adipogenesis paradigm for this study is provided in the supplement (Figure 1).

Figure 4: Lipid formation was assessed at Day 3 and Day 7 after miR-205 over-expression and inhibition in 3T3-L1 cells. (A) Oil red O staining at Day 3 revealed
significantly increased lipid staining in the miR-205 inhibited cells compared to those over-expressing miR-205. (B) Spectrophotometric quantification of extracted oil
red O stain (n=8 each group) at day 3. (C) Cell cycle proliferation was assessed in 3T3-L1 cells 48 hours after transfection with pre and anti-mIR-205 using BrdU elisa
(n=8, each group).
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at Day 3 followed by decline (Figure 3c). MiR-205 was unique insofar
as its expression was significantly elevated at all-time points during
adipogenesis in parallel with expression of the PPARγ gene (Figures
3e,3d). By integrating separate datasets of genome wide PPARγ
binding sites in 3T3-L1 cells John et al. [17] determined that miRs103-1, 182/96/183, 205 and 378 are regulated by PPARγ.
Results from our analyses reveal significant inhibition of miRs-182
and 205 in the VA of obese NZ10 mice and increased expression of
miR-205 in 3T3-L1 during adipogenesis (Figure 3e) [17]. This is the
first study to show inhibition of miRs- 182 and 205 in VA of obesediabetic mice. The functions of these miRNAs in preadipocytes are
still unknown. Because PPARγ levels are not induced in 3T3-1 cells
until adipogenesis is induced [18] we chose to assess the role of miR205 independently of PPARγ in the preadipocyte stage. To this end
we modified miR-205 expression in 3T3-L1 preadipocytes with either
pre or anti-miRs and evaluated cell cycle proliferation. These results
show a significant increase in preadipocyte proliferation by inhibition
of miR-205 (Figure 4C). MiR-205 has been shown to target ErbB3 in
cancer cells and it is known that ErbB3 is expressed in 3T3-L1 cells
[19,20]. In addition to this upon adding the adipogenesis induction
medium to 3T3-L1 cells after miRNA modulation and staining for lipid
formation at Day 3, we found significantly increased oil red O staining
in the miR-205 inhibited group (Figure 4A, 4B). We hypothesize that
miR-205 targets ErbB3 in adipocytes and enhances proliferation; this
in turn enhances adipogenesis and lipid production in cultured 3T3L-1
cells after induction to differentiate.

Conclusion
This is the first study to show diet-regulation of obesity-related
miRNAs in a mouse model of polygenic susceptibility for obesity and
type 2 diabetes. We show for the first time that miR-205 inhibition
in 3T3-L1 preadipocytes increases cell proliferation and lipid
accumulation after adipogenic induction.
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